제품 정보로 건너뛰기
1 1

Cloud-clone

SKU(재고 관리 코드):PAD022Bo01

Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1)

Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1)

UOM
Concentration
Organism species

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Product No.

PAD022Bo01

Organism Species

Bos taurus; Bovine (Cattle).

Source

Polyclonal antibody preparation

Host

Rabbit

Potency

n/a

Ig Type

IgG

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Label

None

Immunogen

n/a

Buffer Formulation

PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

Traits

Liquid

Concentration

500µg/mL

Organism Species More

Homo sapiens (Human)

Applications

WB; IHC; ICC; IP.

If the antibody is used in flow cytometry, please check FCM antibodies.

UOM

20µl 100µl 200µl 1ml 10ml

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against FGL1. It has been selected for its ability to recognize FGL1 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine

Citations

J Hepatol.

The role of Hepassocin in the development of non-alcoholic fatty liver disease Pubmed: 23792031

Diabetes Management

Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease Futuremedicine:Source

United States Patent Application

Compositions and Methods for Diagnosing Lung Cancer y2016:0077095.html

Cell

Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC Doi: 10.1016/j.cell.2018.09.053

Liver Research

Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus?


Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus


Catalog No.

Related products for research use of Bos taurus; Bovine (Cattle) Organism species

Applications (RESEARCH USE ONLY!)

RPD022Bo01

Recombinant Fibrinogen Like Protein 1 (FGL1)

Positive Control; Immunogen; SDS-PAGE; WB.

PAD022Bo01

Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1)

WB; IHC; ICC; IP.

LAD022Bo71

Biotin-Linked Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1)

WB; IHC; ICC.

 

전체 세부 정보 보기